ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 153 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9,209 | -45.5% | 8,372 | -38.6% | 0.00% | -50.0% |
| Q1 2024 | $16,897 | +96.3% | 13,627 | +66.3% | 0.00% | 0.0% |
| Q4 2023 | $8,606 | -30.7% | 8,196 | +351.8% | 0.00% | -50.0% |
| Q3 2023 | $12,426 | +29.4% | 1,814 | +95.9% | 0.00% | +33.3% |
| Q2 2023 | $9,603 | +31.5% | 926 | +2.5% | 0.00% | +50.0% |
| Q1 2023 | $7,305 | -31.6% | 903 | +33.2% | 0.00% | -50.0% |
| Q4 2022 | $10,679 | +6.8% | 678 | +8.7% | 0.00% | 0.0% |
| Q3 2022 | $10,000 | – | 624 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,399,034 | $49,422,000 | 10.17% |
| VR Adviser, LLC | 4,563,962 | $66,360,000 | 9.07% |
| COMMODORE CAPITAL LP | 2,672,346 | $38,856,000 | 9.00% |
| TCG Crossover Management, LLC | 1,082,213 | $15,735,000 | 7.37% |
| Foresite Capital Management V, LLC | 1,258,243 | $18,295,000 | 4.50% |
| Parkman Healthcare Partners LLC | 1,025,522 | $14,911,000 | 3.29% |
| Aisling Capital Management LP | 634,455 | $9,225,000 | 3.25% |
| GREAT POINT PARTNERS LLC | 800,000 | $11,632,000 | 2.58% |
| Samsara BioCapital, LLC | 794,171 | $11,547,000 | 2.24% |
| Affinity Asset Advisors, LLC | 400,000 | $5,816,000 | 2.11% |